<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> is characterized by the association of <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> and cerebrovascular ischemic events </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical and MRI aspects are described in 26 patients with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MRI features were classified in 6 groups according to the aspect and topography of the lesions </plain></SENT>
<SENT sid="3" pm="."><plain>No correlation was found between the presence of vascular risk factors, valvulopathy or <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and the presence of <z:hpo ids='HP_0000726'>dementia</z:hpo> or MRI lesions </plain></SENT>
<SENT sid="4" pm="."><plain>There was a significant correlation between MRI extension of the lesions and clinical disability </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical course and MRI findings are presented according to the treatment </plain></SENT>
</text></document>